Victor Panagiotakopoulos

Victor Panagiotakopoulos

Auto-generated profile, based on publicly available information

Victor Panagiotakopoulos

Department of Cardiac Surgery, Evangelismos General Hospital, Athens, Greece

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2008 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
IKIoannis Koukis
Ioannis Koukis
MAMihalis Argiriou
Mihalis Argiriou
ADAntonia Dimakopoulou
Antonia Dimakopoulou
VPVictor Panagiotakopoulos
Victor Panagiotakopoulos
NTNikolaos Theakos
Nikolaos Theakos
CCChristos Charitos
Christos Charitos
The use of opioid analgesics to control pain after median sternotomy in cardiac surgical patients is worldwide accepted and established. However, opioids have a wide range of possible side effects, concerning prolonged extubation time, gastrointestinal tract dyskinesia and urinary tract disorders mostly retention. All these may lead to a prolonged ICU stay or overall hospitalization time increase. To determine whether a continuous subcutaneous regional anesthetic infusion delivered directly to the sternotomy site would result in decreased levels of postoperative pain and opioid requirements in cardiac surgical patients undergoing median sternotomy. The continuous subcutaneous infusion (OnQ Painbuster system) was applied in 37 patients. 3 patients were exempted due to prolonged ICU stay. 29 patients underwent CABG, 5 had AVR, 1 MVR and modified Maze, 1 patient had a 3-valve repair due to endocarditis and another one had reconstruction of the left ventricle. Requirements of opioid analgesics were recorded for 96 hours after operation. Pain was assessed using the visual analog scale and the total postoperative hospital length of stay was also measured. The postoperative pain was significantly diminished (0 - 3 at VAS). The mean postoperative length of stay was 5,8 days, rather improved compared to the average stay of 6,7 days. Continuous subcutaneous infusion of ropivacaine directly at the median sternotomy significantly diminishes postoperative pain and the need for opioid analgesic use. Moreover, it seems to reduce overall postoperative length of stay for all cardiac surgical patients.